Related Experiment Videos
[Acute myelomonocytic and monoblastic leukemia with polyradicular symptoms]
Abstract:
Meningeal leukaemia, developed in 4 female patients with M4 or M5 leukaemia during a period of haematological remission. Polyradicular symptoms and signs dominated neurologically, but 3 patients also exhibited cranial nerve palsies. The neurological findings showed no reversal following intrathecal chemotherapy with normalization of liquor cytology. Patchy demyelinization in the region of the anterior spinal roots and of the proximal segments of the affected cranial nerves were responsible for the neurological features. Peripherally located streaky demyelinization of the olfactory bulb and of the optic chiasm were not found to cause any neurological manifestations.
Insights
Meningeal leukaemia can cause neurological issues like polyradicular symptoms and cranial nerve palsies, even during remission. This study found patchy demyelination responsible for these symptoms, which did not improve with chemotherapy.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Meningeal leukaemia, a serious complication of acute myeloid leukaemia, can present with neurological symptoms.
- Understanding the neurological manifestations and underlying pathology is crucial for patient management.
Observation:
- Four female patients with M4 or M5 acute myeloid leukaemia developed meningeal leukaemia during haematological remission.
- Neurological presentation was dominated by polyradicular symptoms and signs, with three patients also experiencing cranial nerve palsies.
Findings:
- Intrathecal chemotherapy led to normalized cerebrospinal fluid cytology but did not reverse the neurological deficits.
- Pathological examination revealed patchy demyelination in the anterior spinal roots and proximal cranial nerves as the cause of neurological features.
Implications:
- The findings highlight demyelination as a key pathological mechanism in meningeal leukaemia-associated neurological dysfunction.
- This suggests that current treatment strategies may need to be re-evaluated for efficacy in addressing the specific neuropathology.
- Further research into neuroprotective strategies or targeted therapies for demyelination in meningeal leukaemia is warranted.